Title Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans.
Author Mateus, Jose; Grifoni, Alba; Tarke, Alison; Sidney, John; Ramirez, Sydney I; Dan, Jennifer M; Burger, Zoe C; Rawlings, Stephen A; Smith, Davey M; Phillips, Elizabeth; Mallal, Simon; Lammers, Marshall; Rubiro, Paul; Quiambao, Lorenzo; Sutherland, Aaron; Yu, Esther Dawen; da Silva Antunes, Ricardo; Greenbaum, Jason; Frazier, April; Markmann, Alena J; Premkumar, Lakshmanane; de Silva, Aravinda; Peters, Bjoern; Crotty, Shane; Sette, Alessandro; Weiskopf, Daniela
Journal Science Publication Year/Month 2020-Oct
PMID 32753554 PMCID PMC7574914
Affiliation + expend 1.Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.

Many unknowns exist about human immune responses to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. SARS-CoV-2-reactive CD4(+) T cells have been reported in unexposed individuals, suggesting preexisting cross-reactive T cell memory in 20 to 50% of people. However, the source of those T cells has been speculative. Using human blood samples derived before the SARS-CoV-2 virus was discovered in 2019, we mapped 142 T cell epitopes across the SARS-CoV-2 genome to facilitate precise interrogation of the SARS-CoV-2-specific CD4(+) T cell repertoire. We demonstrate a range of preexisting memory CD4(+) T cells that are cross-reactive with comparable affinity to SARS-CoV-2 and the common cold coronaviruses human coronavirus (HCoV)-OC43, HCoV-229E, HCoV-NL63, and HCoV-HKU1. Thus, variegated T cell memory to coronaviruses that cause the common cold may underlie at least some of the extensive heterogeneity observed in coronavirus disease 2019 (COVID-19) disease.

  • Copyright © 2023
    National Institute of Pathogen Biology, CAMS & PUMC, Bejing, China
    All rights reserved.